(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 4. Abnormal pharyngeal arch arteries in Alk2/Wnt1-Cre mutants. Left
lateral view after intracardiac ink injection to visualize developing
pharyngeal arch arteries at E10.5 (A, B) and at E11.5 (C,D) in controls (A,C)
and Alk2 mutants (B,D). The pharyngeal arch arteries are numbered.
Note regression of arteries 3 and 6 in the Alk2 mutant at E11.5.
Immunohistochemistry for the smooth muscle cell marker,
-smooth muscle
actin at E11.0 in control (E,G) and Alk2 mutant samples (F,I). The
high-power pictures show the 6th pharyngeal arch artery in the control (G,H)
and mutant (I,J). There is diffuse discontinuous brown staining around the 3rd
and 6th pharyngeal arch arteries at E11.0 in mutants (I, arrows in J) when
compared with controls (G,H). Neural crest cells were fate mapped using the
WNT1-Cre/R26R reporter assay (H,J; green) to show that in controls (H) and in
mutants (J) the aortic arch arteries are surrounded by NCCs. Scale bars: 200
µm in E,F; 50 µm in G-J.